Baci-rx

   
Google
 
Web NewDrugInformation.com

Baci-rx


Drug - Baci-rx
The trade name of the product as shown on the labeling.

Dosage - POWDER; FOR RX COMPOUNDING
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Bacitracin
Multiple ingredients are in alphabetical order.

Strength - 5,000,000 UNITS/BOT
The potency of the active ingredient(s), Bacitracin. May repeat for multiple part products.

Applicant - PHARMA TEK
The firm name holding legal responsibility for Baci-rx. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 061580
The FDA assigned number to Baci-rx. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Baci-rx. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AA
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Baci-rx was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Baci-rx. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Baci-rx is in. Format is RX, OTC, DISCN.

Applicant Full Name - Pharma Tek Inc
The full name of the firm holding legal responsibility for the new application of Baci-rx.

Baci-rx